Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: BIOMARKER and IMAGING CHARACTERISATION of INFLAMMATORY ATHEROMA in PATIENTS RECEIVING IMMUNOTHERAPY and ANGIOGENESIS INHIBITORS
A clinical trial update describes biomarker and imaging characterization of inflammatory atheroma in cancer patients receiving immunotherapy…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID) [NA]
This update reports the completion and results posting of PROMPT-LIPID, a pragmatic trial assessing whether targeted messaging to providers …
-
FDA approval · 2024-08-20FDA Approved: REPATHA — Supplemental Application (Amgen USA Inc.)
FDA approves a supplemental application for Repatha (evolocumab) from Amgen USA Inc., authorizing changes related to its labeling/indication…
-
FDA approval · 2024-08-20FDA Approved: PITAVASTATIN — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for pitavastatin (generic), authorizing its manufacture and sale as a statin …
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED) [Phase 3]
A completed Phase 3 trial evaluated MK0653A in combination with simvastatin for cholesterol lowering in patients with hypercholesterolemia a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Recipe for Heart Health [NA]
A completed clinical trial update from the University of Florida related to atherosclerotic cardiovascular disease. The study status is comp…
-
FDA approval · 2024-07-26FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for atorvastatin calcium from Micro Labs Limited, updating the approval status of this generic stati…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Real Life Lipid Management in Hospitals Not Participating in PENELOPE Trial - Control Population for PENELOPE
Real-world lipid management study is completed, serving as the control population for the PENELOPE trial.
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists
This completed study assessed real-world awareness and perceptions of systemic inflammation and the role of hsCRP as a biomarker among nephr…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia
This completed real-world study evaluated adherence, treatment patterns, patient characteristics, and effectiveness of Inclisiran in patient…
-
FDA approval · 2024-07-15FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for a generic ezetimibe and simvastatin combination product (EZETIMIBE AND SIMVASTATIN) from Ascend …
-
FDA approval · 2024-07-11FDA Approved: FLUVASTATIN SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Fluvastatin Sodium (generic) from Lannett Company, Inc., confirming regulatory approval for this…
-
FDA approval · 2024-07-11FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for atorvastatin calcium from Aurobindo Pharma Limited, confirming approval of a generic atorvastati…
-
FDA approval · 2024-07-11FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for atorvastatin calcium from NorthStar RxLLC, resulting in the approval of a generic atorvastatin c…
-
FDA approval · 2024-07-10FDA Approved: EZETIMIBE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for ezetimibe (ANDA 210859). This is a routine supplemental approval for a gen…
-
FDA approval · 2024-07-10FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental ANDA for atorvastatin calcium, enabling Zydus Lifesciences Limited to market a generic atorvastatin calcium prod…
-
FDA approval · 2024-07-10FDA Approved: EZETIMIBE — Supplemental Application (Marlex Pharmaceuticals, Inc.)
The FDA approved a supplemental application for ezetimibe submitted by Marlex Pharmaceuticals, Inc., granting an update to the approved gene…
-
FDA approval · 2024-07-10FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic Ezetimibe and Simvastatin combination from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Medical Students' Evaluation of Dyslipidemia and LIPoprotein(a) Study
A ClinicalTrials.gov study led by the University of Ioannina is evaluating the prevalence of elevated lipoprotein(a) among Greek medical stu…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Multi-omics Merge for Ensemble Subtyping for Atherosclerotic Cardiovascular Disease
This clinical trial update describes a study on multi-omics ensemble subtyping for atherosclerotic cardiovascular disease, with enrollment n…
-
FDA approval · 2024-06-17FDA Approved: EZETIMIBE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for ezetimibe from Ascend Laboratories, LLC.
-
FDA approval · 2024-06-14FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for atorvastatin calcium from NorthStar RxLLC, authorizing a generic version of atorvastatin.
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease [Phase 3]
Phase 3 cardiovascular outcome trial evaluating obicetrapib in patients with atherosclerotic cardiovascular disease; the study is currently …
-
FDA approval · 2024-06-03FDA Approved: EZETIMIBE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ezetimibe from Aurobindo Pharma Limited, confirming regulatory approval of this generic ezetimib…
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Impact of the Genetic Background as a Risk Factor for Atherosclerotic Cardiovascular Disease in the Brazilian Population
This clinical trial update reports on studying how genetic background affects risk of atherosclerotic cardiovascular disease in Brazil; the …